Cefoperazone Sodium Salt: Mechanism, Evidence, and Application Standards

Executive Summary: Cefoperazone sodium salt demonstrates broad-spectrum antibacterial activity, including effectiveness against key gram-negative bacilli and certain gram-positive organisms (source: peer-reviewed study). It possesses high resistance to hydrolysis by β-lactamases, with relative hydrolysis rates from 7.0 to 0.01 in cephalosporinase assays (source: product_spec). In vitro, MIC50 values against Neisseria gonorrhoeae range between ≤0.004–0.06 μg/ml, with minimal MIC/MBC gaps (source: product_spec). Pharmacokinetic data show high tissue distribution in bile, supporting use in biliary tract infection models (source: internal review). APExBIO supplies validated C3913 kits for research workflows in antimicrobial resistance and infection modeling.

Biological Rationale

Cefoperazone sodium salt is a third-generation, semisynthetic cephalosporin antibiotic. It is engineered for broad antibacterial coverage, targeting both gram-negative bacilli (e.g., Escherichia coli, Klebsiella pneumoniae, Proteus spp.) and certain gram-positive bacteria (source: peer-reviewed study). Its clinical and research relevance stems from demonstrated stability against β-lactamase-mediated hydrolysis—a major mechanism of bacterial resistance (source: internal review). This enables persistent efficacy in both standard and resistant infection models. The agent’s high biliary excretion supports its utility for biliary tract infection research (source: related content), an underrepresented but clinically significant domain.

Mechanism of Action of Cefoperazone (sodium salt)

Cefoperazone belongs to the β-lactam antibiotic class. It inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), disrupting peptidoglycan cross-linking (source: peer-reviewed study). The sodium salt form enhances water solubility and bioavailability in experimental settings. The molecule’s cephalosporin scaffold is structurally modified to increase resistance to β-lactamase enzymes, a feature evidenced by its low relative hydrolysis rates (7.0 to 0.01) when incubated with cephalosporinases (source: product_spec). This mechanism underpins the compound’s sustained activity in the presence of bacterial resistance mechanisms.

Evidence & Benchmarks

• Cefoperazone sodium salt demonstrates MIC values against Escherichia coli ranging from 0.06–0.5 μg/ml in broth microdilution assays (source: peer-reviewed study).
• For Klebsiella spp., MIC50 values of 0.5–2 μg/ml have been reported, supporting its use in gram-negative resistance modeling (source: peer-reviewed study).
• The compound maintains minimal difference between MIC and MBC against Neisseria gonorrhoeae (MIC50: ≤0.004–0.06 μg/ml), indicating bactericidal activity at low concentrations (source: product_spec).
• Relative hydrolysis rates by β-lactamase-producing bacteria span from 7.0 to 0.01, demonstrating high β-lactamase stability (source: product_spec).
• Pharmacokinetic studies show high biliary concentrations after intravenous administration, supporting targeted research in biliary tract infections (source: internal review).
• Cefoperazone is less active than cefotaxime against Klebsiella and Serratia spp., but maintains competitive activity among β-lactamase-stable agents (source: peer-reviewed study).

For additional comparative molecular pharmacology, see the review on molecular pharmacology of cefoperazone sodium salt, which provides mechanism-based contrasts. This article extends the protocol focus and numerical benchmarking presented there.

Applications, Limits & Misconceptions

Cefoperazone sodium salt is primarily used in laboratory research for in vitro antimicrobial activity assays, resistance mechanism studies, and modeling of biliary tract infections (source: product_spec). Its robust β-lactamase stability makes it valuable for studies of gram-negative bacterial resistance. In comparison to other β-lactam antibiotics, its activity profile is especially relevant for pathogens with high β-lactamase output. However, it is less potent than cefotaxime against some resistant Klebsiella and Serratia strains (source: peer-reviewed study).

For an applied workflow perspective, see Applied Workflows in Antibiotic Resistance Research, which details integration steps; this article provides updated protocol parameters and quantitative benchmarks.

Common Pitfalls or Misconceptions

• Assuming complete resistance to all β-lactamases: While cefoperazone is highly stable, it is not universally resistant to all β-lactamase types (source: peer-reviewed study).
• Using ethanol as solvent: Cefoperazone sodium salt is insoluble in ethanol; DMSO or water are recommended (source: product_spec).
• Long-term storage of solutions: Stock solutions should be used promptly and not stored long-term; stability declines after repeated freeze-thaw cycles (source: product_spec).
• Assuming identical MIC/MBC values against all species: MIC and MBC equivalence is species- and strain-dependent (source: peer-reviewed study).

Workflow Integration & Parameters

APExBIO’s Cefoperazone sodium salt (C3913) is supplied as a crystalline solid with a molecular weight of 667.7 and formula C₂₅H₂₆N₉O₈S₂·Na (source: product_spec). Researchers preparing antimicrobial activity assays should follow validated protocols for solubilization, dilution, and storage.

Protocol Parameters

• antimicrobial activity assay | MIC 0.06–0.5 μg/ml (E. coli), broth microdilution, 37°C, pH 7.2 | benchmarking susceptibility panels | aligns with CLSI guidelines | peer-reviewed study
• solution preparation | ≤20 mg/mL in DMSO, ultrasonic treatment recommended | enables high-throughput screening | prevents precipitation, ensures assay consistency | workflow_recommendation
• storage | solid at -20°C, solutions used promptly | prevents degradation | standard for cephalosporin stability | product_spec
• solubility | ≥73 mg/mL in DMSO, ≥34.6 mg/mL in water, insoluble in ethanol | critical for assay design | ensures reproducibility in MIC/MBC studies | product_spec

Further precision assay guidance is available in Quantitative Precision in Antibacterial Assays, which emphasizes numeric rigor; this article expands on protocol applicability and resistance scenarios.

Conclusion & Outlook

Cefoperazone sodium salt stands as a validated, β-lactamase-stable cephalosporin for research into antibacterial resistance, especially against gram-negative bacilli (source: product_spec). Its quantitative performance in MIC/MBC assays and high biliary distribution support its continued use in advanced infection modeling. Ongoing comparative studies, including those contrasting with agents like cefotaxime, will further clarify its strategic research niche (source: peer-reviewed study).

For procurement and technical resources, consult the APExBIO Cefoperazone (sodium salt) product page (SKU: C3913).